Skin permeation and distribution of two sunscreens: A comparison between reconstituted human skin and hairless rat skin

Skin Pharmacology and Physiology

Volumn 21, Issue 6, 2008, Pages 318-325

  Monti, D ^a   Brini, I ^a   Tampucci, S ^a   Chetoni, P ^a   Burgalassi, S ^a   Paganuzzi, D ^b   Ghirardini, A ^b  

^a UNIVERSITY OF PISA   (Italy)

^b Bottega Verde ^*  (Italy)

Author keywords

In vitro percutaneous absorption; Rat skin; Reconstructed human epidermis; Skin distribution profile; Sunscreens

Indexed keywords

2 PHENOXYETHANOL; ACYLGLYCEROL; ALPHA TOCOPHEROL; BUTYL PARABEN; CETOSTEARYLIC ALCOHOL; CITRIC ACID; DIMETICONE; ETHYL PARABEN; ETHYLHEXYLMETHOXYCINNAMATE; ETHYLHEXYLTRIAZONE; EXCIPIENT; GLYCEROL; GLYCEROL STEARATE; HYDROGENATED CASTOR OIL; HYDROXYMETHYLCELLULOSE; LANOLIN; MAGNESIUM SULFATE; METHYL PARABEN; POLIDOCANOL; POLYETHYLENE GLYCOL 20 GLYCERYL STEARATE; POLYGLYCOL 2 DIPOLYHYDROXYSTEARATE; PROPYL PARABEN; SUNSCREEN; UNCLASSIFIED DRUG; UVINUL MC80; UVINUL T150;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; DRUG DISTRIBUTION; DRUG FORMULATION; EMULSION; HAIRLESS RAT; IN VITRO STUDY; LIPID COMPOSITION; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; SKIN ABSORPTION; SKIN CULTURE; SKIN PERMEABILITY;

ANIMALS; CINNAMATES; HUMANS; MALE; MODELS, BIOLOGICAL; ORGANIC CHEMICALS; PERMEABILITY; RATS; REPRODUCIBILITY OF RESULTS; SKIN; SKIN ABSORPTION; SPECIES SPECIFICITY; SUNSCREENING AGENTS; TISSUE CULTURE TECHNIQUES; TISSUE DISTRIBUTION; VEHICLES;

EID: 51249084957     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000154927     Document Type: Article

References (30)

1. Eide MJ, Weinstock MA: Public health challenges in sun protection. Dermatol Clin 2006;24:119-124.
2. Nohynek GJ, Schaefer H: Benefit and risk of organic ultraviolet filters. Regul Toxicol Pharmacol 2001;33:285-299.
3. 2006/647/EC: commission recommendation of 22 September 2006 on the efficacy of sunscreen products and the claims made relating thereto, notified under document No C (2006) 4089. Official Journal of the European Union, L265/39, 26 September 2006.
4. Potard G, Laugel C, Baillet A, Schaefer H, Marty JP: Quantitative HPLC analysis of sunscreens and caffeine during in vitro percutaneous penetration studies. Int J Pharm 1999;189:249-260.
5. Jimènez MM, Pelletier J, Bobin MF, Martini MC: Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate. Int J Pharm 2004;272:45-55.
6. Jiang R, Roberts MS, Collins DM, Benson HA: Absorption of sunscreens across human skin: an evaluation of commercial products for children and adults. Br J Clin Pharmacol 1999;48:635-637.
7. Diembeck W, Beck H, Benech-Kieffer F, Courtellemont P, Dupuis J, Lovell W, Paye M, Spengler J, Steiling W: Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem Toxicol 1999;37:191-205.
8. Couteau C, Perez Cullel N, Connan AE, Coiffard LJM: Stripping method to quantify absorption of two sunscreens in human. Int J Pharm 2001;222:153-157.
9. Hayden CGJ, Cross SE, Anderson C, Saunders NA, Roberts MS: Sunscreen penetration of human skin and related keratinocyte toxicity after topical application. Skin Pharmacol Physiol 2005;18:170-174.
10. Weigmann HJ, Jacobi U, Antoniou C, Tsikrikas GN, Wendel V, Rapp C, Gers-Barlag H, Sterry W, Lademann J: Determination of penetration profiles of topically applied substances by means of tape stripping and optical spectroscopy: UV filter substance in sunscreens. J Biomed Opt 2005;10:14009.
11. Yener G, Hadgraft J, Pugh WJ: Penetration of two sunscreens in various formulations through a synthethic membrane as compared to human skin in vitro. Acta Pharm Turc 1998;1:27-32.
12. Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending council directive 76/768/EEC on the approximation of the laws of the member states relating to cosmetic products, Official Journal L66, 11 March 2003, p 26.
13. Cohen C, Dossou G, Rougier A, Roguet R: Episkin: an in vitro model for the evaluation of the phototoxicity sunscreen photoprotective properties. Toxicol In Vitro 1994;8:669-671.
14. Ponec M, Kempenaar J: Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritant. Skin Pharmacol 1995;3:126-135.
15. Doucet O, Garcia N, Zastrow I: Skin culture model: a possible alternative to the use of excised human skin for assessing in vitro percutaneous absorption. Toxicol In Vitro 1998;12:423-430.
16. Schmook FP, Meingassner JG, Billich A: Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm 2001;215:51-56.
17. Monti D, Saettone MF, Giannaccini B, Galli-Angeli D: Enhancement of transdermal penetration of dapiprazole through hairless mouse skin. J Control Rel 1995;33:71-77.
18. Wagner H, Kostka KH, Lehr CM, Schaefer UF: Human skin penetration of flufenamic acid: in vivo/in vitro correlation (deeper skin layers) for skin samples from the same subject. J Invest Dermatol 2002;118:540-544.
19. Wagner H, Kostka KH, Lehr CM, Schaefer UF: Drug distribution in human skin using two different in vitro test systems: comparison with in vivo data. Pharm Res 2000;17:1475-1481.
20. Potard G, Laugel C, Schaefer H, Marty JP: The stripping technique: in vitro absorption and penetration of five UV filters on excised fresh human skin. Skin Pharmacol Appl Skin Physiol 2000;13:336-344.
21. Van Ravenzwaay B, Leibold E: A comparison between in vitro rat and human and in vivo rat skin absorption studies. Hum Exp Toxicol 2004;23:421-430.
22. Netzlaff F, Lehr CM, Wertz PW, Schaefer UF: The human epidermis models Episkin, Skinethic and Epiderm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm 2005;60:167-178.
23. Williams AC, Barry WB: Penetration enhancers. Adv Drug Del Rev 2004;56:603-618.
24. Kanikkannan N, Kandimalla K, Lamba SS, Singh M: Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 2000;7:593-608.
25. Vicanovâa J, Mommaas AM, Mulder AA, Koerten HK, Ponec M: Impaired desquamation in the in vitro reconstructed human epidermis. Cell Tissue Res 1996;286:115-122.
26. Mak VH, Cumpstone MB, Kennedy AH, Harmon CS, Guy RH, Potts RO: Barrier function of human keratinocyte cultures grown at the air-liquid interface. J Invest Dermatol 1991;96:323-327.
27. Netzlaff F, Kaca M, Bock U, Haltner-Ukomadu E, Meiers P, Lehr CM, Schaefer UF: Permeability of the reconstructed human epidermis model Episkin in comparison to various human skin preparations. Eur J Pharm Biopharm 2007;66:127-134.
28. Gray GM, Yardley HJ: Lipid compositions of cells isolated from pig, human and rat epidermis. J Lipid Res 1975;16:434-440.
29. Sato K, Sugibayashi K, Morimoto Y: Species differences in percutaneous absorption of Nicorandil. J Pharm Sci 1991;80:104-107.
30. Schürer NY, Plewig G, Elias PM: Stratum corneum lipid function. Dermatologica 1991;183:77-94.